Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Terret

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Definition and outline on geriatric oncology]C Terret, J-P Droz
The Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P Armand
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Psycho-oncological aspects of urological cancers in the elderly subject]P Saltel, C Terret, C Dionne
Annals of the New York Academy of Sciences|December 13, 1996
CPT-11. The European experienceJ P Armand, C Terret, C Couteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2006
The illness trajectory of elderly cancer patients across cultures: SIOG position paperA Surbone, M Kagawa-Singer, C Terret, et al.
Bulletin Du Cancer|January 1, 1996
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]C Couteau, K Yakendji, C Terret, et al.
Anti-Cancer Drugs|September 23, 2000
Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activityI Hennebelle, C Terret, E Chatelut, et al.
British Journal of Cancer|July 17, 1999
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissuesS Guichard, C Terret, I Hennebelle, et al.
Cancer Treatment Reviews|September 28, 2021
Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literatureC de la Fouchardiere, L Decoster, E Samalin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)C Terret, S Zanetta, H Roché, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Definition and outline on geriatric oncology]C Terret, J-P Droz
The Journal of Infusional Chemotherapy|July 1, 1996
CPT-11: the European clinical developmentC Terret, C Couteau, J P Armand
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Psycho-oncological aspects of urological cancers in the elderly subject]P Saltel, C Terret, C Dionne
Annals of the New York Academy of Sciences|December 13, 1996
CPT-11. The European experienceJ P Armand, C Terret, C Couteau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2006
The illness trajectory of elderly cancer patients across cultures: SIOG position paperA Surbone, M Kagawa-Singer, C Terret, et al.
Bulletin Du Cancer|January 1, 1996
[Taxotere (docetaxel) and CPT 11 (irinotecan): phase I trials]C Couteau, K Yakendji, C Terret, et al.
Anti-Cancer Drugs|September 23, 2000
Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activityI Hennebelle, C Terret, E Chatelut, et al.
British Journal of Cancer|July 17, 1999
CPT-11 converting carboxylesterase and topoisomerase activities in tumour and normal colon and liver tissuesS Guichard, C Terret, I Hennebelle, et al.
Cancer Treatment Reviews|September 28, 2021
Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literatureC de la Fouchardiere, L Decoster, E Samalin, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the EORTC Early Clinical Study Group (ECSG)C Terret, S Zanetta, H Roché, et al.
Pageof 2